A Six-Gene Signature Predicts Survival of Patients with Localized Pancreatic Ductal Adenocarcinoma
Jeran K. Stratford(RTI International), Jen Jen Yeh(University of North Carolina at Chapel Hill), Christine A. Iacobuzio–Donahue(Johns Hopkins University), Keith A. Volmar(University of North Carolina at Chapel Hill), Mark S. Talamonti(NorthShore University HealthSystem), Laura S. Caskey(University of North Carolina at Chapel Hill), Leigh B. Thorne(University of North Carolina at Chapel Hill), Judy M. Anderson, Charles M. Perou(University of North Carolina at Chapel Hill), Channing J. Der(University of North Carolina at Chapel Hill), J. S. Marron(University of North Carolina at Chapel Hill), Han Jo Kim(University of North Carolina at Chapel Hill), Cheng Fan(University of North Carolina at Chapel Hill), Jonathan C. Samuel(University of North Carolina at Chapel Hill), Benjamin F. Calvo(University of North Carolina at Chapel Hill), Elizabeth D. Routh(University of North Carolina at Chapel Hill), David J. Bentrem(Northwestern University), Michael A. Hollingsworth(University of Nebraska Medical Center)
Cited by 251
Related Papers
Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis
|The Lancet|2014|4.7k
Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses
|Science|2008|4k
Immunohistochemical and Clinical Characterization of the Basal-Like Subtype of Invasive Breast Carcinoma
|Clinical Cancer Research|2004|2.7k
Organoid Models of Human and Mouse Ductal Pancreatic Cancer
|Cell|2014|2.2k
Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer
|Breast Cancer Research|2010|2.1k